Knowles Julius has filed 7 insider transactions across 1 company since April 2020.
Most recent transaction: a disposition of 191527 shares of Keros Therapeutics, Inc. ($KROS) on November 21, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 21, 2025 | Keros Therapeutics, Inc. | $KROS | Knowles Julius | Not found | D | Common Stock | 191527 | $17.75 | 156,488.0000 | 41,202,371 | 55.03% | 0.46% |
| Nov. 21, 2025 | Keros Therapeutics, Inc. | $KROS | Knowles Julius | Not found | D | Common Stock | 130494 | $17.75 | 108,674.0000 | 41,202,371 | 54.56% | 0.32% |
| June 4, 2025 | Keros Therapeutics, Inc. | $KROS | Knowles Julius | Not found | A | Stock Option (right to buy) | 10500 | $0.00 | 10,500.0000 | 37,437,652 | 9999.99% | 0.03% |
| June 4, 2025 | Keros Therapeutics, Inc. | $KROS | Knowles Julius | Not found | A | Common Stock | 5250 | $0.00 | 580,742.0000 | 37,437,652 | 0.91% | 0.01% |
| May 30, 2024 | Keros Therapeutics, Inc. | $KROS | Knowles Julius | Not found | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 29,447,119 | 9999.99% | 0.03% |
| June 6, 2023 | Keros Therapeutics, Inc. | $KROS | Knowles Julius | Director | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 25,241,030 | 9999.99% | 0.04% |
| April 13, 2020 | Keros Therapeutics, Inc. | $KROS | Knowles Julius | Director | P | Common Stock | 1191 | $20.98 | 575,492.0000 | 0 | 0.21% | 0.00% |